​
​

AbCellera Biologics (ABCL) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

AbCellera Biologics Revenue Highlights

Latest Revenue (Y)

$38.02M

Latest Revenue (Q)

$6.51M

Main Segment (Y)

Research Fees

Main Geography (Y)

CANADA

AbCellera Biologics Revenue by Period

AbCellera Biologics Revenue by Year

DateRevenueChange
2023-12-31$38.02M-92.17%
2022-12-31$485.42M29.38%
2021-12-31$375.20M60.92%
2020-12-31$233.16M1907.96%
2019-12-31$11.61M31.49%
2018-12-31$8.83M-

AbCellera Biologics generated $38.02M in revenue during NA 2023, up -92.17% compared to the previous quarter, and up 430.59% compared to the same period a year ago.

AbCellera Biologics Revenue by Quarter

DateRevenueChange
2024-09-30$6.51M-11.14%
2024-06-30$7.32M-26.43%
2024-03-31$9.95M8.44%
2023-12-31$9.18M39.10%
2023-09-30$6.60M-34.38%
2023-06-30$10.06M-17.52%
2023-03-31$12.19M-43.41%
2022-12-31$21.55M-78.75%
2022-09-30$101.38M120.80%
2022-06-30$45.92M-85.50%
2022-03-31$316.58M127.22%
2021-12-31$139.33M2429.61%
2021-09-30$5.51M-80.07%
2021-06-30$27.64M-86.37%
2021-03-31$202.74M-2.49%
2020-12-31$207.91M2120.77%
2020-09-30$9.36M-16.62%
2020-06-30$11.23M141.10%
2020-03-31$4.66M45.42%
2019-12-31$3.20M-7.20%
2019-09-30$3.45M39.20%
2019-06-30$2.48M-0.00%
2019-03-31$2.48M-

AbCellera Biologics generated $6.51M in revenue during Q3 2024, up -11.14% compared to the previous quarter, and up 64.71% compared to the same period a year ago.

AbCellera Biologics Revenue Breakdown

AbCellera Biologics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21
Royalty-$443.00M$327.30M
License$969.00K$696.00K$20.78M
Milestone Payments$1.50M$900.00K$8.00M
Research Fees$35.56M$40.80M$19.08M

AbCellera Biologics's latest annual revenue breakdown by segment (product or service), as of Dec 23: Research Fees (93.51%), Milestone Payments (3.94%), and License (2.55%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
Research Fees$6.29M$9.77M$8.74M$6.41M$9.83M$10.57M$11.42M$7.51M$12.54M$9.33M$4.75M$5.13M$5.21M$3.99M
License$218.00K$180.00K$185.00K$186.00K$226.00K$372.00K$165.00K$154.00K$147.00K$231.00K$86.00K$190.00K$263.00K$20.26M
Milestone Payments--$250.00K--$1.25M$500.00K$400.00K--$1.00M$7.00M--
Royalty------$9.46M$93.32M$33.23M$307.02M$134.50M$190.00K$21.16M$171.50M

AbCellera Biologics's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Research Fees (96.65%), and License (3.35%).

AbCellera Biologics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21
CANADA$36.00M$484.20M$353.40M
UNITED STATES$2.00M$1.20M$21.80M

AbCellera Biologics's latest annual revenue breakdown by geography, as of Dec 23: CANADA (94.74%), and UNITED STATES (5.26%).

AbCellera Biologics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
SRPTSarepta Therapeutics$1.24B$362.93M
PTCTPTC Therapeutics$937.82M$135.42M
VIRVir Bio$86.18M$2.38M
CVACCureVac$52.70M$12.37M
KRYSKrystal Biotech$50.70M$83.84M
ABCLAbCellera Biologics$38.02M$6.51M
IOVAIovance Biotherapeutics$1.19M$58.55M
CWBRCohBar--
AVROAVROBIO--
MDGLMadrigal Pharmaceuticals-$62.17M
HEPAHepion Pharmaceuticals--

ABCL Revenue FAQ

What is AbCellera Biologics’s yearly revenue?

AbCellera Biologics's yearly revenue for 2023 was $38.02M, representing a decrease of -92.17% compared to 2022. The company's yearly revenue for 2022 was $485.42M, representing an increase of 29.38% compared to 2021. ABCL's yearly revenue for 2021 was $375.2M, representing an increase of 60.92% compared to 2020.

What is AbCellera Biologics’s quarterly revenue?

AbCellera Biologics's quarterly revenue for Q3 2024 was $6.51M, a -11.14% decrease from the previous quarter (Q2 2024), and a -1.39% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $7.32M, a -26.43% decrease from the previous quarter (Q1 2024), and a -27.18% decrease year-over-year (Q2 2023). ABCL's quarterly revenue for Q1 2024 was $9.95M, a 8.44% increase from the previous quarter (Q4 2023), and a -18.36% decrease year-over-year (Q1 2023).

What is AbCellera Biologics’s revenue growth rate?

AbCellera Biologics's revenue growth rate for the last 3 years (2021-2023) was -89.87%, and for the last 5 years (2019-2023) was 227.48%.

What are AbCellera Biologics’s revenue streams?

AbCellera Biologics's revenue streams in c 23 are License, Milestone Payments, and Research Fees. License generated $969K in revenue, accounting 2.55% of the company's total revenue, up 39.22% year-over-year. Milestone Payments generated $1.5M in revenue, accounting 3.94% of the company's total revenue, up 66.67% year-over-year. Research Fees generated $35.56M in revenue, accounting 93.51% of the company's total revenue, down -12.86% year-over-year.

What is AbCellera Biologics’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of AbCellera Biologics was Research Fees. This segment made a revenue of $35.56M, representing 93.51% of the company's total revenue.